1Sachs RN, Valensi P, Lormeau B, et al. Determinants of echocardiographically measured LVM in diabetic patients with or without silent myocardial ischaemia. Diabetes Metab, 1999,25(2): 128
3Levy D, Garrison RJ,Savage DD, et al. Left ventricular mass predicts coronary disease events independent of the standard risk factors (abstract) Circulation, 1987,76(suppl) Ⅳ - 435
4Krisian K, Yres D, Sandrine M, et al. "Uremic cardiomyopaty".Nephrol Dial Transplant, 1998,13(Suppl4) :39
7Piovesan A, Casasso F. Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy. Clin Endocrinol Oxf, 1999,50(3) :321
8Wu Y, Kumar R. parathyroid hormone regulates transforming growth factor beta 1 and beta 2 synthesis in osteoblasts via divergent signaling pathways. J Bone Miner Res, 2000,15(5): 879
10Cheol WP, Yong SS, et al. Infro venous calcitrid regresses myocardial hypertrophy in bemodialysis patient with secondary hyperparathyroidism.Am J Kidney Dis,1999,33(1)73
二级参考文献30
1[1]Kristian K,Yres D,Sandrine M et al."Uremic Cardiomyopathy”Nephrol Dial Transplant,1998,13(Suppl 4):39
2[2]Sahn DJ,De Maria A.Recommendations regarding quantitation in M-mode echocardiographic measurements.Circulation,1978,58:1072
3[3]Devereux RB,Reichek N.Echocardiographic determination of left ventricular mass in man:Anatomic validation of the method.Circulation,1977,55:613
4[4]Kannel WB,Gordon T,Offutt D.Left ventricular hypertrophy by electrocardiogram:Prevalence,incidence and mortality in the Framingham Study.Ann Intern Med,1969,71:89
5[5]Kannel WB,Doyle JT,McNamara PM et al.Precursors of sudden coronary death:Factors related to the incidence of sudden death.Circulation,1975,51:606
6[6]Levy D,Garrison RJ,Savage DD et al.Left ventricular mass predicts coronary disease events independent of the standard risk factors(abstract).Circulation,1987,76(Suppl Ⅳ):Ⅳ-435
7[7]Parfrey PS,Harnett JD,Griffiths SM et al.The clinical course of left ventricular hypertrophy in dialysis patients.Nephron,1990,55:114
8[8]Greaves SC,Gamble GD,Collins JF et al.Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure.Am J Kidney Dis,1994,24(5):768
3Habener JF.Recent advances in parathyroid hormone research[J].Clin.Biochem,1981,14(5) 223-229.
4Rao DS,Shih MS,Mohini R.Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia[J].N Eng1 J Med,1993,328(3):171-175.
5Izquierdo A,Lpez-Luna P,Ortega A,et al.The parathyroid hormonerelated protein system and diabetic nephropathy outcome in streptozotocin-induced diabetes[J].Kidney International,2006,69,2171-2178.
6Urena P,Eckardt KU,Sarfati E,et al.Serum erythropoietin and erythropoiesis in primary and secondary hyperparathyroidism:Effect of parathyroidectomy[J].Nephron,1991,59:384-393.
7Elvira Femandez,Merce Borras,Beatriz P,et al.Low-calcium dialysate stimulates parathormone secretion and its long-termuse worsens secondary hyperparathyroidism[J].Am Soc Nephrol,1995,6(1):132-135.
8Fujii H, Kim Jl, Abe T, et al. Relationship between parathyroid hormone and cardiac abnormalities in chronic dialysis patients[ J]. Intern Med ,2007,46 ( 18 ) : 1507-1512.
9De Boer IH, Gorodetskaya I, Young B, et al. The severity of sec- ondary hyperparathyroidism in chronic renal insufficiency is GFR- dependent, race-dependent, and associated with cardiovascular dis- ease [ J ]. J Am Soc Nephrol, 2002, 13 ( 11 ) :2762 -2769.
10Saleh FN, Schirmer H, Sundsford J, et al. Parathyroid hormone and left ventricular hypertrophy [ J ]. Eur Heart J, 2003,24 ( 22 ) : 2054-2060.
